Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

New handheld heart monitor is a breakthrough for childhood cancer survivors

June 22, 2018 | Maxine Nunes

A new electronic monitor called Vivio, developed by Caltech with City of Hope, promises to make cardiac screening easier and more accessible for cancer patients and physicians.

City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer

June 8, 2018 | Letisia Marquez

Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.

Researchers Discover Breakthrough Treatment For Advanced Squamous Cell Carcinoma

June 7, 2018 | Maxine Nunes

A couple of years ago, Timothy Satterfield, a retired chef, noticed a tiny mole on his forehead. He was referred to City of Hope, where a breakthrough immunotherapy trial is proving to be a game changer.

Meet Kim Margolin, M.D.: Leading the fight against melanoma - and winning

May 28, 2018 | Maxine Nunes

When Kim Margolin, M.D., talks about her work, the words are packed with information and pour out with energy and passion. It’s easy to see what makes her an internationally recognized leader in the fight against melanoma.

City of Hope Physicians and Researchers Announce Breakthroughs at AACR 2018

April 19, 2018 | Leticia Marquez

City of Hope scientists and doctors presented their latest cancer research at the annual meeting of the American Association for Cancer Research at Chicago’s McCormick Place on April 14 to 18.

CAR T Laboratory Research Yields Promising Prostate Cancer Results

April 17, 2018 | Letisia Marquez

City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.

Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery

March 26, 2018 | City of Hope

City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.

Leukemia Drug Shows Promise Against Rare Ovarian Cancer

March 2, 2018 | City of Hope

City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.